Connect with us

Technology

Alveo Technologies Begins Shipping the First Point-of-Need™ Molecular Test for Avian Influenza in Poultry to the EU

Published

on

Chris Cowen, seasoned global commercial executive in Life Sciences, joins as Chief Commercial Officer to drive future growth and scale

ALAMEDA, Calif., Oct. 31, 2024 /PRNewswire/ — Alveo Technologies, Inc. (Alveo), a leader in decentralized molecular diagnostics with its proprietary IntelliSense™ platform, today announced the launch of its first animal health diagnostic product, the Alveo Sense Avian Influenza Test. The Alveo Sense Avian Influenza Panel provides fast, precise results in the field with geotagged results and cloud-based analytics immediately accessible in the cloud.

The product is launching in partnership with Netherlands-based Royal GD, a leading organization in the field of animal health, monitoring, and improvement of animal health in livestock farming as well as UK-based x-OvO. The first shipments are now reaching early-access customers across the EU through established sales channels, with further expansion planned throughout the EMEA region.

With this launch, Alveo has positioned itself for rapid growth with a significant expansion beyond human health. To manage this growth, Alveo has hired Chris Cowen, formerly VP of Global Commercial Operations for the Genetic Sciences Division at Thermo Fisher Scientific, as Chief Commercial Officer. Chris will drive Alveo’s global sales, marketing, and distribution efforts. 

Revolutionizing Avian Influenza Detection: Faster, Safer, Smarter

Alveo’s decentralized molecular diagnostic test detects and differentiates between Avian Influenza Type A, H5 and H7 or H9. Previously, testing required shipping and transport of potentially hazardous samples to a central lab for processing and then waiting days, even weeks to receive a result, causing costly delays. The Alveo Sense Avian Influenza Test works on both cloacal and oropharyngeal samples to deliver precise results within 30-45 minutes. Using Alveo’s secure Alveo Vista™ portal, geotagged results are instantly uploaded to the cloud, giving public health authorities real-time insights into viral outbreaks, empowering rapid containment measures.

“Avian influenza has been devastating to the poultry industry, and producers, vets and authorities need a decentralized, fast and accurate test,” said Wim Kieftenbeld, Business Development at Royal GD.  “The Alveo Sense Avian Influenza Test fills that gap with the first rapid molecular test that can be used at the point of need.”

Addressing a Global Crisis with Cutting-Edge Technology

Since 2021, highly pathogenic avian influenza (HPAI) has affected more than 103 million birds in the United States, alone, according to the USDA. The CDC reports that HPAI has been detected in at least 48 mammalian species, including domestic cattle. The spread to mammals is especially concerning to authorities, because the more species HPAI infects, the greater the chance the virus will mutate to spread efficiently among humans. The CDC reports 15 confirmed cases of HPAI in humans following exposure to infected cattle, but to date, the virus does not appear to be easily contracted by one person from another.

“x-OvO Limited has focused on the subject of avian RNA virus diagnostics for 17 years,” said Richard Currie, President of x-OvO. “Our decision to partner with Alveo to develop an avian influenza test was driven by the potential flexibility and adaptability of their platform. The ability to detect multiple targets using both cloacal and oropharyngeal samples covers more variation in notifiable disease targets than single reaction real-time PCR can achieve.”

By decentralizing testing, eliminating reliance on central labs, and uploading geotagged results to the cloud, the Alveo Sense Avian Influenza Test provides authorities with a real-time view of outbreaks via the Alveo Vista portal. This real-time view mitigates trade disruption due to concerns about importing infected poultry and reduces consumption used by lab-based PCR analyzers and packaging waste. Alveo’s tests can also determine whether vaccinated poultry are contagious, reducing risk from vaccinated birds that can harbor and spread the virus without displaying symptoms.

“Our platform can detect a wide range of pathogens with high precision, quickly at the point of need,” said Shaun Holt, CEO of Alveo Technologies. “The launch of this product and partnership with Royal GD and x-OvO represents a critical step toward advancing animal health and creating a future where portable, accurate, and accessible molecular testing becomes the standard across the agricultural sector.”

For more information on the Alveo Sense Avian Influenza Test visit: https://www.alveotechnologies.com/alveo-sense-poultry 

About Alveo  
Alveo is the first company to make molecular detection and diagnostics universally accessible – on the farm, in the field, in the clinic, or in the manufacturing plant – helping prevent or significantly limit the destructive impact of viruses, fungi, bacteria, and other pathogens by detecting earlier at the Point of Need™. Alveo’s portable, multiplex-capable diagnostic platform employs IntelliSense™, its patented method of direct electrical sensing of nucleic acid amplification to provide affordable, rapid, and accurate results. By enabling early pathogen detection, Alveo helps manage global health, food security, and supply chain resiliency by providing actionable insights at lightspeed. Know Sooner, Act Faster™ with Alveo. For more, visit:  https://www.alveotechnologies.com/alveo-sense-poultry 

Contact:
Jeff Miller 
jeff@marketstreetgrp.com
541-207-6413

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alveo-technologies-begins-shipping-the-first-point-of-need-molecular-test-for-avian-influenza-in-poultry-to-the-eu-302292795.html

SOURCE Alveo Technologies

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

World IP Day 2026: PitchMark launches Ideas.Exchange to help creators safeguard and license ideas in the age of AI

Published

on

By

SINGAPORE, April 26, 2026 /PRNewswire/ — To mark World IP Day 2026, PitchMark® today launched Ideas.Exchange, a first‑of‑its‑kind platform designed to help creators assert intellectual property rights, license ideas, and formalise creative conversations in an increasingly AI‑driven economy.

Unveiled at Safeguard Your IP in the Age of AI, a media briefing hosted by CNBC’s Sri Jegarajah, the platform responds to growing concern that ideas are routinely used, reused or absorbed without attribution, consent or compensation—often with limited legal or commercial recourse.

“AI has amplified both the reach and the risk for creators,” said Mark Laudi, Managing Partner of PitchMark LLP. “Ideas.Exchange gives creators a way to protect themselves while still participating confidently in the market for ideas.”

At its core, the platform focuses on three interventions for creators:

Asserting IP rights by establishing proof of authorship and precedenceLicensing ideas without giving them away for freeFormalising conversations so pitches and evaluations are governed rather than informal

Ideas.Exchange is powered by three proprietary resources developed by PitchMark. These include a blockchain‑driven clearing house where ideas and creative works can be listed and licensed; smart contracts that automate usage terms and reduce disputes; and an IP Governance Certification Program designed to signal responsible handling of ideas, particularly in enterprise and AI contexts.

The result, PitchMark says, is three concrete outcomes: deterrence of idea theft, new ways to monetise ideas through structured licensing and price discovery, and a more level playing field that allows creators to pitch to clients and platforms on equal terms.

The launch comes amid renewed scrutiny of how intellectual property is treated in the AI era. While idea theft is rarely reported, its impact is significant. Beyond visible financial losses, organisations and creators often absorb hidden costs through talent attrition, innovation suppression and abandoned market opportunities.

“Most idea theft occurs informally and never reaches the courts,” said Prof David Llewelyn, Professor Emeritus of Law at Singapore Management University. “Introducing governance, traceability and standards is a meaningful step toward addressing that gap.”

Spokespeople including Prof Llewelyn, technology lawyer Bryan Ghows, and Mark Laudi are available for interview.

About PitchMark

PitchMark® deters idea theft and enables creatives to get paid by providing a trusted way to share and license ideas with prospects and clients.

 

View original content:https://www.prnewswire.com/apac/news-releases/world-ip-day-2026-pitchmark-launches-ideasexchange-to-help-creators-safeguard-and-license-ideas-in-the-age-of-ai-302753571.html

SOURCE PitchMark

Continue Reading

Technology

SK hynix receives 2026 IEEE Corporate Innovation Award for Driving AI Computing Expansion with HBM

Published

on

By

SK hynix honored at the 2026 IEEE Awards for leading AI technology innovation with HBM Contributed to the global AI computing ecosystem via stable mass production across all HBM generationsCompany committed to becoming a premier leader in AI innovation through collaboration with global customers and partners

SEOUL, South Korea, April 25, 2026 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) announced today that it received the Corporate Innovation Award at the ‘2026 IEEE1 Honors Ceremony’ held in New York on the 24th (local time).

IEEE is the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. Established more than a century ago, the IEEE Awards Program recognizes individuals and teams whose innovations have advanced technology and improved the human condition.

The IEEE Corporation Innovation Award, part of the Recognitions category, has been presented since 1986 to companies that have significantly contributed to the advancement of industry and society through innovative technology. This marks the first time SK hynix has received this honor.

SK hynix attributed the honor to its contribution to the global AI computing ecosystem by ensuring the stable mass production of all High Bandwidth Memory (HBM) generations. Looking ahead, the company aims to solidify its position as a trusted partner in the global AI market by providing memory solutions that are critical to overcoming the performance limitations of AI platforms.

The recognition highlights SK hynix’s achievements in driving the expansion of AI computing through HBM innovation and application. Central to this success was the company’s ability to preemptively offer innovative HBM solutions and respond timely to customer demands in the global AI market.

Industry observers also credit this achievement to the strategic direction of SK Group Chairman Chey Tae-won, who has long emphasized securing long-term technological competitiveness. Under his leadership, the company has consistently expanded its AI infrastructure partnerships with global Big Tech firms in the United States.

Ahn Hyun, President and Chief Development Officer (CDO), attended the ceremony as the company representative to accept the award.

“It is an honor to receive this award on behalf of our employees, who have tirelessly challenged the limits of technology,” said Ahn. “By collaborating closely with our global customers and partners, we will stay ahead in creating the value the market demands and continue to be a premier company leading AI innovation.”

About SK hynix Inc.
SK hynix Inc., headquartered in Korea, is the world’s top-tier semiconductor supplier offering Dynamic Random Access Memory chips (“DRAM”) and flash memory chips (“NAND flash”) for a wide range of distinguished customers globally. The Company’s shares are traded on the Korea Exchange, and the Global Depository shares are listed on the Luxembourg Stock Exchange. Further information about SK hynix is available at www.skhynix.com, news.skhynix.com.

About IEEE
IEEE is the world’s largest technical professional organization and a public charity dedicated to advancing technology for the benefit of humanity. Through its highly cited publications, conferences, technology standards, and professional and educational activities, IEEE is the trusted voice in a wide variety of areas ranging from aerospace systems, computers, and telecommunications to biomedical engineering, electric power, and consumer electronics. Learn more at https://www.ieee.org.

View original content:https://www.prnewswire.com/news-releases/sk-hynix-receives-2026-ieee-corporate-innovation-award-for-driving-ai-computing-expansion-with-hbm-302753615.html

SOURCE SK hynix Inc.

Continue Reading

Technology

NCL (Formerly Natural Cure Labs) Unveils New Brand Identity, Reinforcing Its Position as a Leading Monolaurin Supplement Company

Published

on

By

Natural Cure Labs, one of the most recognized monolaurin supplement brands in the United States, is officially transitioning to NCL – the same company, same formulations, and same science-backed standards, under a streamlined name.

ST. PETERSBURG, Fla., April 25, 2026 /PRNewswire-PRWeb/ — Natural Cure Labs, one of the most recognized monolaurin supplement brands in the United States, is officially transitioning to NCL. The company, founded in 2015, is adopting a streamlined brand identity while maintaining the same formulations, manufacturing standards, team, and commitment to quality its customers have trusted for more than a decade.

“NCL represents the quality, transparency, and innovation that our community expects from us. As we enter this new chapter, our commitment to our customers and our standards remains as strong as ever.”

NCL stands for Natural Cure Labs. The name change reflects how customers and the team already refer to the company. Over the past 10+ years, “NCL” has become the natural shorthand for Natural Cure Labs – and this transition formalizes that identity. This is a name change and visual evolution only. Ownership, leadership, formulations, and values remain unchanged.

Same Mission, Sharper Identity

This transition is not a departure from who the company is – it is a natural progression. The values that have guided NCL from the very beginning remain unchanged: clean-label quality, third-party testing, science-backed formulations, and an unwavering commitment to transparency. What is changing is how the company presents itself. In the months ahead, this rebrand will be accompanied by further updates across the brand experience – from visual identity and packaging to how NCL shows up across every channel and platform. Each of these changes will reflect the same standard of excellence customers have come to expect.

What is changing is how the company presents itself. In the months ahead, this rebrand will be accompanied by further updates across the brand experience – from visual identity and packaging to how NCL shows up across every channel and platform. Each of these changes will reflect the same standard of excellence customers have come to expect.

More Than 10 Years of Trust

This evolution comes at a time of significant momentum. Since 2015, NCL has grown from a small startup into an award-winning wellness brand available nationwide through Amazon, Walmart, Target+, TikTok Shop, eBay, and other major marketplaces. Along the way, the company has reached milestones that reflect the trust its community has placed in it:

200,000+ customers served worldwide35+ million capsules sold7,000+ verified customer reviewsRecognition in the 2025 Inc. 5000 list of fastest-growing private companiesMultiple Stevie Awards from the American Business AwardsNamed a 2025 and 2026 Gator100 HonoreeThree-time Global 100 winner for Best Health & Wellness Nutrition Manufacturer

“This rebrand isn’t about changing who we are – it’s about evolving how we present ourselves to match the brand our customers already know and trust,” said Damon Sununtnasuk, Founder & CEO.

What This Means for Customers

For existing customers, nothing changes about the products they know and trust. The same formulations, manufacturing facilities, quality controls, and customer support team remain in place. Products sold as Natural Cure Labs and products sold as NCL are from the same company. Customers can continue to find NCL products on the company’s website and through Amazon, Walmart, Target+, Kroger, eBay, and other major marketplaces.

NCL is grateful for every customer who has been part of this journey and is excited for what is to come.

Media Contact

NCL (Natural Cure Labs), NCL (Natural Cure Labs), 1 8003036214, press@naturalcurelabs.com, https://www.naturalcurelabs.com/

View original content to download multimedia:https://www.prweb.com/releases/ncl-formerly-natural-cure-labs-unveils-new-brand-identity-reinforcing-its-position-as-a-leading-monolaurin-supplement-company-302753477.html

SOURCE NCL (Natural Cure Labs)

Continue Reading

Trending